
Deciphera Pharmaceuticals, a member of the ONO Group, develops and commercializes innovative oncology therapeutics. Leveraging a proprietary switch-control kinase inhibitor platform, the company focuses on discovering novel treatments that target dysregulated kinase pathways in cancer. Its deep expertise in kinase biology enables a broad portfolio of medicines designed to improve patient outcomes. Deciphera’s distinctive approach combines cutting-edge science with a commitment to delivering high-impact therapies to patients worldwide.
We’re looking for a highly skilled Medical Science Liaison II to serve as a field-based scientific expert within oncology, building and maintaining peer-to-peer relationships with key opinion leaders and providing balanced, evidence-based information on investigational and marketed therapies.
Deciphera Pharmaceuticals, a member of the ONO Group, develops and commercializes innovative oncology therapeutics. Leveraging a proprietary switch-control kinase inhibitor platform, the company focuses on discovering novel treatments that target dysregulated kinase pathways in cancer. Its deep expertise in kinase biology enables a broad portfolio of medicines designed to improve patient outcomes. Deciphera’s distinctive approach combines cutting-edge science with a commitment to delivering high-impact therapies to patients worldwide.